p53 gene mutations in non-small cell lung cancer from Thai patients

Journal of the Medical Association of Thailand

Volumn 82, Issue 3, 1999, Pages 250-255

  Petmitr, Songsak ^a   Makthiengtrong, Siriwan ^a   Sutinont, Pantap ^a   Migasena, Panata ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Lung cancer; p53 gene; Thai patients

Indexed keywords

ARTICLE; CLINICAL TRIAL; CULTURE TECHNIQUE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THAILAND; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CULTURE TECHNIQUES; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 0033088913     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vatanasapt V, Martin N, Sriplug H, et al. Cancer in Thailand 1988-1991. IACR Technical report no. 16 1996; 164.
2. Weinberg RA. Molecular mechanisms of carcinogenesis. In: Leder P, et al. eds. Introduction to molecular medicine, Scientific American Inc. New York 1994; 277-305.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
4. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer epidemiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
5. Murakami Y, Hayaki K, Sekiya T. Detection of aberations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res 1991; 51: 3356-61.
6. Soussi T, Cardon de Fromentel, May P. Structure aspects of the p53 protein in relation to gene evoluation. Oncogene 1990; 5: 945-52.
7. Canman CE, Chen C-Y, Lee M-H, Kastan MB. DNA damage response : p53 induction, cell cycle perturbations, and apoptosis. Cold Spring Harbor Sym Quant Biol 1994; 59: 277-86.
8. Ryberg D, Kure E, Lystad S, et al. p53 Mutations in lung tumors : relationship to putative susceptibility markers for cancer. Cancer Res 1994; 54: 1551-5.
9. Ronnai A, Gradia S, Peterson A, Hecht S. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-methylnitrosoamino-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridylxobutylatiog agents. Carcinogenesis 1993; 14: 2419-22.
10. Rideout WM, Coetzee GA, Olumi AF, Lones PA. 5-Methyl cytosine as an endogenous mutagent in the human LDL receptor and p53 gene. Science 1990; 249: 1288-90.
11. Soussi T. The p53 tumor suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 1996; 1: 32-7.
12. Dennis Q, Ann D, Carol S, Herbert W, Himansh D. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992; 52: 4828-31.
13. World Health Organization. Histological typing of lung tumors. 2nd ed. International histological classification of tumors, Geneva: WHO, 1981.
14. Tada M, Omata M, Ohto M. Analysis of ras gene mutation in human hepatic malignant tumours by polymerase chain reaction and direct sequencing. Cancer Res 1990; 50: 1122-4.
15. Shopland DR, Eyre HJ, Pechacek TF. Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smoker in the United States? J Natl Cancer Inst 1991; 83: 1142-8.
16. Hoffmann D, Rivenson A, Murphy E, et al. Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived N-nitrosamines. J Smoking Rel Disord 1993; 4: 165-90.
17. Eric E, Jane W, Janin P, et al. Carcinogenic epoxides of benzo(a)pyrene and cyclopental[ed] pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci USA 1982; 79: 1945-9.
18. Horsfall MJ, Gardon AJ, Burns PA, et al. Mutational specificity of alkylating agents and the influence of DNA repair. Environ Mol Mutagen 1990; 15: 1107-12.
19. Fukuyama Y, Mitsudomi T, Sugio T, Akazawz K, Sugimachi K. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small cell lung cancer. Br J Cancer 1997; 75: 1125-30.
20. Sukuki H, Takahashi T, Kuroishi T, et al. p53 mutation in non-small cell lung cancer in cancer in Japan : association between mutations and smoking. Cancer Res 1992; 52: 734-6.
21. Arthur B, Gary B, Timothy S, Paul T, Michael S. Tumor suppressor genes : prospects for cancer therapies. Bio Tech 1995; 13: 127-31.